Global Health Clinics Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA37958W3012
CAD
0.03
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Global Health Clinics Ltd. stock-summary
stock-summary
Global Health Clinics Ltd.
Pharmaceuticals & Biotechnology
Global Health Clinics Ltd is a Canada-based company focused on the cannabis industry. The Company operates through its subsidiaries, including Patient Access Pavilions Ltd. (PAP) and MCRCI Medicinal Cannabis Resource Centre Inc. (MCRCI). PAP is a marketing technology company. PAP utilizes a digital platform generating qualified leads through storefront kiosks operating in, among other areas, marijuana dispensaries in British Columbia. PAP offers sorting and recording of patient information as well as verification and allows a gateway between health service providers and medical marijuana patients. MCRCI operates medical clinics which guides patients through the process of becoming legal users of medical marijuana. MCRCI operates a virtual clinic in British Columbia through affiliate agreements with doctors.
Company Coordinates stock-summary
Company Details
400 - 837 West Hastings Street , VANCOUVER BC : V6C3N6
stock-summary
Tel: 1 604 2831722
stock-summary
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Apr 2025)
Net Profit:
0 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 0 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.41

stock-summary
Return on Equity

29.90%

stock-summary
Price to Book

-0.03